venetoclax
abbvie,heidelberg pharmaceuticals,janssen,roche
['myeloid', 'leukemia', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'venetoclax', 'heidelberg', 'janssen']
#ash22 #leusm renders: macs-score, a lsc based predictor of clinical response to ven and other bh3 mimetics. to replace conventional chemo with hma/ven based in a broader, younger population, it will be useful to have a biomarker predicting ven response. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)